Exeter Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $416K | Sell |
17,278
-166
| -1% | -$4.34K | 0.16% | 80 |
|
|
2026
Q1 | $490K | Sell |
17,444
-100
| -0.6% | -$2.66K | 0.2% | 79 |
|
|
2025
Q4 | $437K | Sell |
17,544
-3,009
| -15% | -$75.9K | 0.19% | 77 |
|
|
2025
Q3 | $524K | Sell |
20,553
-835
| -4% | -$20.6K | 0.23% | 76 |
|
|
2025
Q2 | $518K | Sell |
21,388
-6,807
| -24% | -$159K | 0.23% | 75 |
|
|
2025
Q1 | $714K | Buy |
28,195
+13,239
| +89% | +$346K | 0.32% | 66 |
|
|
2024
Q4 | $397K | Sell |
14,956
-13,755
| -48% | -$373K | 0.18% | 76 |
|
|
2024
Q3 | $831K | Buy |
28,711
+843
| +3% | +$24.6K | 0.37% | 66 |
|
|
2024
Q2 | $780K | Buy |
27,868
+682
| +3% | +$18.8K | 0.37% | 64 |
|
|
2024
Q1 | $725K | Buy |
27,186
+11,704
| +76% | +$325K | 0.33% | 67 |
|
|
2023
Q4 | $455K | Sell |
15,482
-12,369
| -44% | -$374K | 0.22% | 69 |
|
|
2023
Q3 | $924K | Buy |
27,851
+869
| +3% | +$30.7K | 0.49% | 58 |
|
|
2023
Q2 | $972K | Sell |
26,982
-9,574
| -26% | -$373K | 0.5% | 57 |
|
|
2023
Q1 | $1.53M | Sell |
36,556
-1,184
| -3% | -$51.1K | 0.76% | 49 |
|
|
2022
Q4 | $1.93M | Buy |
37,740
+639
| +2% | +$30.6K | 1.01% | 44 |
|
|
2022
Q3 | $1.62M | Buy |
37,101
+464
| +1% | +$22.5K | 0.94% | 45 |
|
|
2022
Q2 | $1.92M | Buy |
36,637
+314
| +0.9% | +$16K | 1.07% | 39 |
|
|
2022
Q1 | $1.88M | Buy |
36,323
+470
| +1% | +$24.4K | 1.02% | 42 |
|
|
2021
Q4 | $2.02M | Buy |
35,853
+303
| +0.9% | +$15K | 1.1% | 35 |
|
|
2021
Q3 | $1.53M | Buy |
35,550
+837
| +2% | +$37.1K | 0.91% | 43 |
|
|
2021
Q2 | $1.38M | Buy |
34,713
+2,351
| +7% | +$91.4K | 0.8% | 45 |
|
|
2021
Q1 | $1.17M | Buy |
32,362
+2,147
| +7% | +$76.2K | 0.74% | 50 |
|
|
2020
Q4 | $1.11M | Sell |
30,215
-552
| -2% | -$20.2K | 0.77% | 48 |
|
|
2020
Q3 | $1.07M | Buy |
30,767
+195
| +0.6% | +$6.84K | 0.84% | 45 |
|
|
2020
Q2 | $949K | Sell |
30,572
-383
| -1% | -$13K | 0.79% | 49 |
|
|
2020
Q1 | $959K | Buy |
30,955
+595
| +2% | +$20.3K | 0.9% | 44 |
|
|
2019
Q4 | $1.13M | Sell |
30,360
-1,087
| -3% | -$38.7K | 0.88% | 47 |
|
|
2019
Q3 | $1.07M | Sell |
31,447
-3,341
| -10% | -$121K | 0.85% | 47 |
|
|
2019
Q2 | $1.43M | Buy |
34,788
+142
| +0.4% | +$5.64K | 1.2% | 36 |
|
|
2019
Q1 | $1.4M | Buy |
34,646
+269
| +0.8% | +$10.8K | 1.21% | 36 |
|
|
2018
Q4 | $1.42M | Buy |
34,377
+47
| +0.1% | +$1.95K | 1.34% | 32 |
|
|
2018
Q3 | $1.44M | Buy |
34,330
+795
| +2% | +$30.6K | 1.18% | 35 |
|
|
2018
Q2 | $1.15M | Buy |
33,535
+1,259
| +4% | +$43K | 1.02% | 42 |
|
|
2018
Q1 | $1.09M | Sell |
32,276
-112
| -0.3% | -$3.85K | 0.93% | 43 |
|
|
2017
Q4 | $1.11M | Buy |
+32,388
| New | +$1.1M | 0.97% | 39 |
|
Other funds holding PFE
AIM
CWP
DADC
Exeter Financial's PFE Position: Q2 2026 in Review
Exeter Financial reduced its Pfizer (PFE) stake by 0.95% in Q2 2026, selling an estimated $4.34K and leaving 17,278 shares worth $416K. The position accounts for 0.16% of the portfolio, ranked #80.
Exeter Financial first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.02M in Q4 2021. 1,102 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Exeter Financial held 17,278 shares of Pfizer worth $416K as of Q2 2026.
- Exeter Financial sold 166 Pfizer shares in Q2 2026, an estimated $4.34K.
- Pfizer made up 0.16% of Exeter Financial's portfolio in Q2 2026, its #80 holding.
- Exeter Financial first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- Exeter Financial's Pfizer position peaked at $2.02M in Q4 2021.
- 1,102 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.